COLONY GROUP LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,209,000
-7.6%
11,590
-11.9%
0.03%
-26.2%
Q3 2019$1,309,000
-20.6%
13,154
-8.9%
0.04%
-19.2%
Q2 2019$1,649,000
-9.1%
14,446
+0.1%
0.05%
-31.6%
Q1 2019$1,814,000
-0.3%
14,433
+7.6%
0.08%
-13.6%
Q4 2018$1,820,000
-46.0%
13,410
+9.1%
0.09%
-47.6%
Q3 2018$3,372,000
+29.7%
12,286
-2.1%
0.17%
+23.5%
Q2 2018$2,600,000
-15.5%
12,550
-32.6%
0.14%
-18.6%
Q1 2018$3,076,000
+18.7%
18,622
-1.6%
0.17%
+3.1%
Q4 2017$2,591,000
-7.9%
18,920
-8.4%
0.16%
-15.6%
Q3 2017$2,813,000
+5.8%
20,660
-5.7%
0.19%
+1.6%
Q2 2017$2,659,000
+13.4%
21,899
-1.2%
0.19%
-14.5%
Q1 2017$2,345,000
+2.2%
22,154
-1.9%
0.22%
-10.2%
Q4 2016$2,295,000
-0.0%
22,589
+0.4%
0.25%
-3.5%
Q3 2016$2,296,000
-16.9%
22,498
-2.9%
0.26%
-16.1%
Q2 2016$2,764,000
+8.6%
23,178
-2.4%
0.30%
+3.4%
Q1 2016$2,544,000
-1.5%
23,760
-0.3%
0.29%
+24.6%
Q4 2015$2,583,000
+27.9%
23,820
+1.0%
0.24%
+0.4%
Q3 2015$2,020,00023,5900.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders